Oncologics Will Need Dual Genetic Tests For Optimally Targeted Treatments
Executive Summary
The key to successful use of targeted oncologic therapies will be routine genetic testing for both the patient and the tumor, Fox Chase Cancer Center Senior VP Robert Ozols suggested at an American Society of Clinical Oncology briefing Dec. 2